DiaMedica Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $30,838 |
Gross Profit | -6,883 | -10 | -8 | 30,830 |
EBITDA | -6,873 | -5,628 | -5,733 | -5,840 |
EBIT | -6,883 | -5,638 | -5,741 | -5,848 |
Net Income | -6,274 | -5,119 | -5,151 | -5,161 |
Net Change In Cash | 0 | 0 | 0 | 30,838 |
Free Cash Flow | -4,479 | -4,519 | -6,662 | -3,582 |
Cash | 4,134 | 14,066 | 2,097 | 4,543 |
Basic Shares | 42,751 | 38,068 | 37,958 | 37,958 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -30 | -25 | -24 | -21 |
EBITDA | -19,308 | -13,976 | -13,622 | -12,244 |
EBIT | -19,338 | -14,001 | -13,646 | -12,265 |
Net Income | -19,381 | -13,676 | -13,592 | -12,292 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 3,526 | |||
Free Cash Flow | -18,752 | -11,592 | -12,274 | -9,232 |
Cash | 4,543 | 4,728 | 4,707 | 7,409 |
Basic Shares | 32,566 | 26,443 | 20,773 | 15,680 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.15 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.14 |
